LPSN

LivePerson, Inc. (LPSN) 2024 Annual Report Summary

Business Context and Reporting Period

This summary covers LivePerson, Inc.'s Form 10-K for the fiscal year ended December 31, 2024. LivePerson is a provider of digital customer conversation solutions, leveraging AI and automation to connect brands with consumers across mobile, web, and voice channels. The company operates as a single reporting segment following the divestiture of its WildHealth business in Q2 2024 and the prior sale of its Kasamba consumer segment.

Key Financial Metrics

Note: Operating margin is calculated as Operating Loss divided by Revenue.

Material Changes vs. Prior Period

• Revenue Decline: Revenue decreased 22% year-over-year, driven by a $71.3 million drop in hosted services (due to customer cancellations and downsells) and an $18.2 million drop in professional services. The 2023 period included $15.8 million of revenue from WildHealth, which was sold in 2024.
• Significant Impairments: The company recorded a $60.6 million goodwill impairment and a $46.9 million impairment of intangibles and other assets. These non-cash charges were primarily due to revised future cash flow projections and the divestiture of WildHealth.
• Debt Restructuring: LivePerson recognized a $73.1 million gain on debt extinguishment following the exchange of $146.0 million of 2026 Notes for new 2029 Notes and the repurchase of additional 2026 Notes.
• Cost Reductions: Operating expenses decreased across all categories (Cost of Revenue -35%, Sales & Marketing -20%, Product Development -20%) primarily due to headcount reductions and lower outsourced labor costs.
• Liquidity: Cash and cash equivalents decreased by $29.7 million, impacted by the repayment of $72.5 million in 2024 Notes and capital expenditures, partially offset by proceeds from new 2029 Notes and a Delayed Draw facility.

Guidance, Outlook, and Risks

• Retention Metrics: Revenue retention for enterprise and mid-market customers was approximately 82% in 2024, below the target range of 105% to 115%. Management expects short-term attrition to continue into the first half of 2025, with a transition to positive net new annual recurring revenue expected in the second half of 2025.
• Debt Covenants: The 2029 Notes require the company to maintain a minimum cash balance of $60.0 million. As of December 31, 2024, the company held $183.2 million in cash, satisfying this covenant.
• Listing Risk: The company's common stock has traded below the $1.00 minimum bid price requirement for The Nasdaq Global Select Market on multiple occasions in 2024. Failure to maintain compliance could result in delisting.
• Refinancing Needs: The company must refinance the remaining $361.2 million of 2026 Notes by December 2026. There is a risk that financing may not be available on commercially reasonable terms.
• Legal Proceedings: The company is subject to ongoing stockholder litigation (including class actions and derivative suits) and a lawsuit filed by Starboard Value LP alleging fraud and misrepresentation.

Key Facts for Investor Verification

• Debt Maturity Wall: Verify the company's ability to refinance the $361.2 million 2026 Notes due in December 2026, noting that the 2029 Notes become due 91 days prior if more than $60 million of 2026 Notes remain outstanding.
• Revenue Retention Trend: Monitor the 82% revenue retention rate and the timeline for achieving positive net new annual recurring revenue in H2 2025.
• Nasdaq Compliance: Track the stock price relative to the $1.00 minimum bid price requirement to assess delisting risk.
• Impairment Drivers: Review the assumptions used in the goodwill and intangible asset impairment tests, specifically regarding future revenue growth and EBITDA projections.
• Litigation Exposure: Assess the potential financial impact of the Starboard Value LP lawsuit and ongoing securities class actions.